Brazil vs Kenya: The number of people with susceptibility test result for rifampicin
Brazil
24,394
in 2021
Kenya
24,832
in 2021
Brazil rank
14th
Kenya rank
13th
The number of people with susceptibility test result for rifampicin over time
- Brazil
- Kenya
How they compare
Kenya currently reports 24,832 against 24,394 in Brazil, a difference of 438.
Across all 5 years both countries report, Kenya has been ahead every year.
Brazil ranks 14th and Kenya ranks 13th of 155 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20,251 | 29,916 | 9,666 | Kenya |
| 2020s | 24,076 | 28,802 | 4,725 | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brazil or Kenya?
- Kenya, at 24,832 against 24,394 in Brazil as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brazil and Kenya?
- 438, with Kenya ahead.
- How many years of comparable data are there for Brazil and Kenya?
- 5 years are reported by both, from 2017 to 2021.
- How do Brazil and Kenya rank globally for the number of people with susceptibility test result for rifampicin?
- Brazil ranks 14th and Kenya ranks 13th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.